Stryker’s AxSOS 3® Ankle Fusion System Offers Innovative Plates That Are Designed to Fit a Range of Patients

New System Includes Titanium Plates with Streamlined Instrumentation and Updated Screw Offerings

MAHWAH, N.J.–(BUSINESS WIRE)–Stryker’s Trauma & Extremities division today announced the launch of its AxSOS 3Ankle Fusion System, an ankle fusion titanium plate system intended for the fusion of the tibio-talar joint.


The AxSOS 3 Ankle Fusion System was developed using SOMA, Stryker’s proprietary orthopaedic design and development system that applies data from over 25,000 CT images of bones across different populations. As a result, these plates were designed to fit a range of patients with less customization.

“The CP design utilized in Stryker’s forefoot and hindfoot plating systems served as the inspiration to take this technology into ankle fusions,” said Keith Wapner, MD* at Penn Medicine, one of the design surgeons. As it relates to mechanical testing, Dr. Wapner said, “Integrating the stability of plate fixation with the compression of the CP screw allows for a stable ankle fusion construct.”

“We combined Stryker’s CP technology from Anchorage 2 with the company’s AxSOS 3 screw system and incorporated several additional instruments to assist with alignment and compression,” said Michael Coughlin, MD* at UCSF Health, one of the design surgeons. “The system is designed to provide surgeons with a dependable, user-friendly, intuitive technology option.”

Additional information about AxSOS 3® Ti Ankle Fusion System can be found at: https://www.bit.ly/ANKLEFUSIONINFO

*Drs. Coughlin and Wapner are paid consultants of Stryker Orthopaedics.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.

A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

This is intended for US distribution only.

AXSOS-BL-3, 08-2020

Contacts

Media Contact
Andrea Sampson, Sullivan & Sampson PR

asampson@sullivanpr.com
714/374-6174

Staff

Recent Posts

Optimi Health Announces Appointment of New Director

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX:…

46 minutes ago

Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients

Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke…

2 hours ago

BC Platforms and GeneVault partner to unlock access to large-scale real-world and genomic data from under-represented populations

Partnership expands BC Platforms' global patient catchment to include an additional 48 million patient lives…

2 hours ago

EPS Corporation Selects ArisGlobal’s LifeSphere® MultiVigilance

Prominent Japan CRO adopts new safety case processing system to further enhance compliance, automation, and…

2 hours ago

DentScribe Joins Henry Schein One API Exchange as an Authorized Integration Vendor

DentScribe now safely and securely integrates with Dentrix to help dental practices build their best…

2 hours ago

Hemogenyx Pharmaceuticals PLC – Issue of Equity

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE…

5 hours ago